XB-ART-57030
Cell
2019 Oct 17;1793:659-670.e13. doi: 10.1016/j.cell.2019.09.017.
Show Gene links
Show Anatomy links
Full-Length P2X7 Structures Reveal How Palmitoylation Prevents Channel Desensitization.
McCarthy AE
,
Yoshioka C
,
Mansoor SE
.
???displayArticle.abstract???
P2X receptors are trimeric, non-selective cation channels activated by extracellular ATP. The P2X7 receptor subtype is a pharmacological target because of involvement in apoptotic, inflammatory, and tumor progression pathways. It is the most structurally and functionally distinct P2X subtype, containing a unique cytoplasmic domain critical for the receptor to initiate apoptosis and not undergo desensitization. However, lack of structural information about the cytoplasmic domain has hindered understanding of the molecular mechanisms underlying these processes. We report cryoelectron microscopy structures of full-length rat P2X7 receptor in apo and ATP-bound states. These structures reveal how one cytoplasmic element, the C-cys anchor, prevents desensitization by anchoring the pore-lining helix to the membrane with palmitoyl groups. They show a second cytoplasmic element with a unique fold, the cytoplasmic ballast, which unexpectedly contains a zinc ion complex and a guanosine nucleotide binding site. Our structures provide first insights into the architecture and function of a P2X receptor cytoplasmic domain.
???displayArticle.pubmedLink??? 31587896
???displayArticle.pmcLink??? PMC7053488
???displayArticle.link??? Cell
???displayArticle.grants??? [+]
Species referenced: Xenopus laevis
Genes referenced: aopep p2rx7 sh3bp4
GO keywords: ligand-gated ion channel activity
???attribute.lit??? ???displayArticles.show???
Figure 1. Overall Architecture of rP2X7 in the Apo State (A–D) The three-dimensional reconstruction of rP2X7 in the apo state, viewed parallel to the membrane (A), perpendicular to the membrane from the extracellular surface (B), from the center of the TM domain toward the cytoplasm (C), and from the intracellular side of the membrane toward the cytoplasm (D). (E) Ribbon representation of rP2X7 receptor corresponding to the apo state reconstruction shown in (A). Each protomer is colored differently. (F) A close-up side view of the cytoplasmic portion of the TM domain, highlighting how the cytoplasmic cap is composed of domain-swapped β strands (β−1, β0, and β15) from each protomer. To improve visual clarity of the cytoplasmic cap, the C-cys anchor and cytoplasmic ballast were removed. (G) Top-down cross-sectional view of the cytoplasmic cap looking toward the cytoplasm. Residues 29–345 and 395–595 of the receptor were removed to improve visual clarity. Each protomer is a different color. (H) To better visualize the spatial interactions between protomers, one protomer is shown in blue, whereas the other two are shown in gray. (I) Ribbon representation of a single subunit of rP2X7 receptor, highlighting P2X receptor domains, including two new domains found only in the P2X7 subtype: the C-cys anchor and the cytoplasmic ballast. The major domains within a protomer are organized by color: extracellular domain in blue, TM domain in green, cytoplasmic cap in cyan, C-cys anchor in purple, and the cytoplasmic ballast in red. The palmitate groups are colored in sand. | |
Figure 2. Ion Channel Pore (A–F) Cartoon representation of rP2X7 structures, shown parallel to the membrane as a side view, top down view of the ion channel pore, and ion permeation pathway, respectively, comparing the apo, closed state (A, C, and E) with the ATP-bound, open state (B, D, and F). Binding of agonist induces conformational changes around the binding pocket that result in outward flexing of the extracellular domain’s core β strands, pulling on TM2, causing outward helix expansion to open the pore. For the pore size plots, colors represent different radii: reddish pink, <1.15 Å; green, between 1.15–2.30 Å; purple, >2.30 Å. The N terminus, TM1, and cytoplasmic ballast were removed from (E) and (F) to improve visual clarity. | |
Figure 3. Extracellular Orthosteric Ligand-Binding Site (A and B) View of the orthosteric binding pocket, comparing key interactions with ATP in rP2X7 (A) and hP2X3 (B). Two conserved phenylalanine residues (F188 and F293, rP2X7 numbering), proposed to stabilize the ATP-binding pocket, are also similar in both structures (residues not shown). (C–F) Surface representation of the binding pocket for rP2X7 in the open state (C) and apo state (E) compared with hP2X3 in the open state (D) and apo state (F). The apo binding pocket of rP2X7 contains a narrow channel (<11 Å orifice) that shields the pocket from solvent, limiting ligand access. The apo binding pocket of hP2X3 is significantly more solvent exposed (17 Å orifice). The orthosteric binding pocket is at a subunit interface, with protomer A shown in green for open state of rP2X7, forest green for open state of hP2X3, red for the apo state of rP2X7, and red-purple for the apo state of hP2X3. Protomer B is shown in gray, and protomer C is shown in white. | |
Figure 4. P2X7 Cytoplasmic Domain; the C-cys Anchor Is Palmitoylated to Modulate Receptor Function by Preventing Desensitization (A) Surface representation of the apo state of rP2X7, highlighting locations of the C-cys anchor and putative phospholipid binding site. (B) Left: the C-cys anchor is a loop containing six cysteine residues and one serine residue that each face toward the plasma membrane. Right: at least four cysteines (C362, C363, C374, and C377) and one serine (S360) on the C-cys anchor are palmitoylated. Palmitoylation of the C-cys anchor is also present in the open state reconstruction but more easily visualized in the higher-resolution apo state map. The higher-resolution apo state reconstruction also reveals that at least one cysteine (C4) in the N terminus is palmitoylated. Because of domain swapping within the context of a trimeric receptor, the N terminus of one protomer is adjacent to the C-cys anchor of an adjacent protomer, grouping together the palmitoylated moieties of different protomers and effectively interlocking them to the membrane. (C and D) Deletion (rP2X7-ΔCcys) of the C-cys anchor (C) or mutation of residues in the C-cys anchor to alanine (rP2X7-CcysMut) to prevent their palmitoylation (D) both result in channels that, when expressed in Xenopus oocytes, nearly completely desensitize during a 30-s application of 100 μM ATP (black bar). Wild-type rP2X7 receptor (rP2X7-WT) does not desensitize. (E) The putative phospholipid binding site, modeled as a PS, is near the middle of the plasma membrane. Each protomer is a different color. | |
Figure 5. P2X7 Cytoplasmic Domain; the Cytoplasmic Ballast Contains a Novel Fold (A) Ribbon representation of one subunit of the open state structure of rP2X7 receptor, shown in orthogonal views. Each of the major P2X7 domains is color coded. The cytoplasmic cap, C-cys anchor, and cytoplasmic ballast domains are highlighted. (B) Ribbon representation of the cytoplasmic ballast of rP2X7 receptor, displaying the secondary structure elements, the two zinc ions, and the guanosine nucleotide. (C) Topology diagram of the cytoplasmic ballast, shown in the same orientation as in (B), revealing a novel fold without structural homology in the PDB. Dashed lines denote un-modeled regions. (D and E) Additional ribbon representations of the cytoplasmic ballast of the rP2X7 receptor, shown in two different orthogonal views from (B), highlighting the relative locations of the zinc ions and the guanosine nucleotide within the ballast fold. The models are missing residues S443–R469 in the apo state and residues S443–R471 in the open state. | |
Figure 6. The P2X7 Cytoplasmic Ballast Contains a Dinuclear Zinc Ion Complex and a High-Affinity Guanosine Nucleotide Binding Site (A) The cytoplasmic ballast from each protomer lies beneath the TM domain from an adjacent protomer. (B) The entire cytoplasmic domain, viewed perpendicular to the membrane from the cytoplasm. Residues S443–R469 are missing from the apo state structure, visualized here, because no density is present in the map. (C) A bottom-up view focused on the center of the cytoplasmic domain, perpendicular to the membrane from the cytoplasm, reveals how, in the context of a trimer, helices α12 and α13 of each cytoplasmic ballast form a hexagonal hole (diameter, ∼14 Å) through which the α9 helix from each protomer (labeled A, B, and C) emerges. This is referred to as the cytoplasmic plug. The entire cytoplasmic domain assembles as a trimer, in part through the interactions at the interface formed by helices α9, α12, and α13. (D) The cytoplasmic dinuclear Zn2+ ion complex is coordinated by seven cysteine residues in a tetrahedral geometry. (E and F) The cytoplasmic guanosine nucleotide binding site, occupied by a GDP molecule, shown in two views highlighting the density for GDP (E) and key interactions made with conserved P2X7 residues (F). (G) Measurement of 3H-GDP saturation binding to the purified, detergent-solubilized rP2X7 receptor using SPA. The Kd for GDP binding was directly measured as 40 ± 10 nM. Error bars represent the standard deviation of three measurements. (H) Inhibition of 3H-GDP binding to the rP2X7 receptor by guanosine nucleotides yields Ki values of 70 ± 10 nM and 150 ± 15 nM for GDP and GTP, respectively. Non-guanosine diphosphate nucleotides do not displace 3H-GDP and thus do not bind to the cytoplasmic domain of the P2X7 receptor. Error bars represent the standard deviation of three measurements. (I) The guanosine nucleotide binding pocket is exposed at the interface between two cytoplasmic ballasts, accessible as a docking site for protein-protein interactions. Each protomer is a different color. | |
Figure 7. Molecular Mechanism of P2X Receptor Gating (A and B) Cartoon models summarizing the gating mechanism for the desensitizing P2X1–6 receptor subtypes (A) compared with the non-desensitizing P2X7 receptor subtype (B). | |
Figure S1. The Cryoelectron Microscopy Data Processing Workflow, Using the Apo State Data of Full-Length rP2X7 as an Example, Related to Figure 1 Particles were picked using DoG Picker and visually checked using RELION. Particles were subjected to multiple rounds of 2D classification in RELION to remove false positive picks. For 3D classification in RELION, an ab initio reconstruction was generated in CryoSPARC and used as the reference model. Multiple rounds of 3D refinements and the final map sharpening were carried out using RELION. | |
Figure S2. Functional Studies and the Overall Architecture of Full-Length rP2X7 in the Open State, Related to Figure 1 (A) ATP-induced rP2X7 currents (100 μM ATP, black bar) do not undergo desensitization. (B) Co-application of 10 μM antagonist A-438079 (red bar) inhibits the rP2X7 receptor current induced by 100 μM ATP (black bar). (C-F) The three-dimensional reconstruction of full-length rP2X7 in the ATP-bound, open state viewed parallel to the membrane as a side view (C), perpendicular to the membrane from the extracellular surface (D), from the center of the TM domain, toward the cytoplasm (E), and from the intracellular side of the membrane, toward the cytoplasm (F). (G) Ribbon representation of a trimeric receptor structure corresponding to the ATP-bound, open state reconstruction shown in (C). Each protomer is represented by a different color. (H) Ribbon representation of a single subunit of the open state structure, highlighting various purinergic receptor domains, including two new domains, the C-cys anchor and the cytoplasmic ballast. The major domains within a protomer are organized by color: extracellular domain in blue, TM domain in green, cytoplasmic cap in cyan, C-cys anchor in purple, and the cytoplasmic ballast in red. The palmitate groups are colored in sand. (I) A close-up side view of the cytoplasmic portion of the TM domain highlighting the interactions that form the cytoplasmic cap. The cytoplasmic cap is composed of domain-swapped β strands (β-1, β0, and β15) from each protomer. To improve visual clarity of the cytoplasmic cap, the C-cys anchor and cytoplasmic ballast have been removed. (J) Top-down cross-sectional view of the cytoplasmic cap looking toward the cytoplasm. Residues 29-345 and 395-595 of the receptor have been removed to improve visual clarity. Each protomer is a different color. | |
Figure S3. Cryoelectron Microscopy Analysis of Full-Length rP2X7 in the Apo and Open States, Related to Figures 1 and S2 (A) Representative electron micrograph of the apo state rP2X7 data. (B) Selected two-dimensional class averages of the electron micrographs of the apo state rP2X7 data. (C, E) The gold-standard Fourier shell correlation curves for the electron microscopy maps of the apo state data (C) and the open state data (E) of rP2X7 are shown in black for the masked map and blue for the unmasked map, and the Fourier shell correlation curves between the atomic model and the final electron microscopy maps are shown in red. (D, F) Angular distribution of particles used for the refinement of the apo state data (D) and the open state data (F). | |
Figure S4. Local Resolution Estimates and Representative Densities of the Reconstructions for the Apo-State and Open-State Data of rP2X7, Related to Figures 1, 4, and S2 (A-F) Local resolution estimation of the reconstructions shown as a side view, a top down view from the extracellular surface, and a bottom up view from the cytoplasmic surface, respectively, for the apo state data (A-C) and open state data (D-F) of rP2X7 receptor. (G, H) Representative protein densities from different regions of the apo state (G) and open state (H) maps of rP2X7 receptor. (I, J) Densities for ATP (I) and putative PS phospholipid (J) in the open state map | |
Figure S5. The Pore-Lining Surface of rP2X7 for the Open and Apo States, Related to Figure 2 (A) Coronal section of a surface representation of the open state of rP2X7 reveals five vestibules (upper, central, extracellular, intracellular vestibule I, and intracellular vestibule II) are located on the molecular three-fold axis. Beyond the TM gate, two additional sites of constriction exist along the three-fold axis (cytoplasmic cap and cytoplasmic plug). (B) Pore-lining surface along the entire axis of rP2X7 for open and apo states. The color of each sphere represents a different radius from the receptor center, as calculated by the program HOLE: reddish pink < 1.15 Å, green between 1.15 – 2.30 Å, and purple > 2.30 Å. (C) Plot of pore radius as a function of distance along the pore axis (focused around the TM gate) for the apo state versus the open state of rP2X7. The positions of the residues making up the narrowest radius for the TM gate in each conformational state are labeled. The Cα position of residue L353 is set as zero. | |
Figure S6. The Dinuclear Zinc Ion Complex, GDP Nucleotide Densities, and Nucleotide Triphosphate Binding in the Cytoplasmic Ballast of rP2X7 Structures, Related to Figures 1, 5, 6, and S2 (A-F) The cytoplasmic ballast of rP2X7 receptor contains density features in the reconstructions that represent the unexpected findings of a zinc ion complex with two Zn2+ ions (Zn1 and Zn2) and a GDP molecule, respectively, for both the apo state (A-C) and open state (D-F) datasets. (A, D) The zinc ion densities are still present when the maps are contoured to a threshold (σ = 25) where the protein density is no longer clearly visible. (B-C, E-F) The residues surrounding the density make interactions consistent with those expected for GDP. Specifically, R546, K583, and R578 make ionic interactions with the phosphates, R574 and the carbonyl of A567 make hydrogen-bonding interactions with the guanine base, and residues L569, Y550, and F591 contribute van der Waal’s interactions to the guanine base. Each of these residues is conserved in human P2X7. The apo state structure is shown in red (B-C) and the open state structure is shown in green (E-F). The densities shown are from the apo and open state maps obtained using a mask that included the TM and cytoplasmic domain, but excluded the extracellular domain (focused refinement on the cytoplasmic domain). (G) Inhibition of 3H-GDP binding to rP2X7 receptor by guanosine nucleotide triphosphates yields Ki values of 150 ± 15 nM and 100 ± 10 nM for GTP and GTP-γ-S, respectively. Non-guanosine nucleotide triphosphates show significantly lower binding affinity – nucleotides UTP and CTP inhibit 3H-GDP binding to rP2X7 receptor with Ki values of 60 ± 10 μM and 130 ± 3 μM, respectively. Nucleotide TTP does not displace 3H-GDP and thus does not bind to the cytoplasmic domain of P2X7 receptor. (H-I) Nucleotide ATP shows a time-dependent displacement of 3H-GDP from the cytoplasmic domain of P2X7 receptor. While no displacement of 3H-GDP occurs initially (H), an ATP-induced displacement of 3H-GDP (Ki value of 22 ± 10 μM) can be measured after several hours (I). A time-dependent change in the displacement of 3H-GDP did not occur with any other nucleotide. Because ATP also binds to the extracellular domain of P2X7 receptor in the orthosteric ATP binding pocket, further studies are needed to determine if the time-dependent displacement of 3H-GDP is due to direct displacement from ATP binding to the cytoplasmic domain or from allosteric modulation, whereby the affinity of 3H-GDP binding to the cytoplasmic domain is decreased after ATP binds to the extracellular, orthosteric ligand binding pocket. Error bars represent the standard deviation of three measurements. | |
Figure S7. GDP Detection Using MRM and Functional Assessment of the Cytoplasmic Ballast, Related to Figures 5 and 6 (A-D) Liquid chromatography tandem mass spectrometry analysis on a purified rP2X7 receptor preparation using multiple reaction monitoring (MRM) of fragment ions (m/z 135 and m/z 152) produced from the parent ion (m/z 444) in positive ESI mode confirm the identification of GDP nucleotide. MRM monitoring ion fragment m/z 152 and ion fragment m/z 135, respectively, for buffer and GDP control (A, C) compared to the receptor sample (B, D). The retention time and ratio of the two ions are consistent with GDP nucleotide. No other nucleotides were detected. (E-H) The functional aspects of rP2X7-ΔBallast are nearly identical to rP2X7-WT with respect to kinetics of activation, lack of desensitization, affinity for ATP, and ion selectivity. (E-F) Both rP2X7-WT (E) and rP2X7-ΔBallast (F) show similar current facilitation, and no desensitization, with repeated exposure to 100 μM ATP (1 minute, black bar) at one minute intervals, for three exposures. (G) ATP-activated dose-response curves for rP2X7-WT (black trace) and rP2X7-ΔBallast (red trace), performed in the absence of divalent cations, show similar EC50 values of 42 ± 3 μM and 52 ± 11 μM, respectively. Error bars represent the standard deviation of three measurements. (H) The ATP-induced (100 μM) two electrode voltage clamp currents for rP2X7-WT (black trace) and rP2X7-ΔBallast (red trace) reversed sign at −8 ± 1 mV and −10 ± 3 mV, respectively. Error bars represent the standard deviation of three measurements. | |
Graphical Abstract |
References [+] :
Adams,
PHENIX: a comprehensive Python-based system for macromolecular structure solution.
2010, Pubmed
Adams, PHENIX: a comprehensive Python-based system for macromolecular structure solution. 2010, Pubmed
Adinolfi, Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor. 2010, Pubmed
Allsopp, The intracellular amino terminus plays a dominant role in desensitization of ATP-gated P2X receptor ion channels. 2011, Pubmed , Xenbase
Allsopp, Contribution of the Juxtatransmembrane Intracellular Regions to the Time Course and Permeation of ATP-gated P2X7 Receptor Ion Channels. 2015, Pubmed , Xenbase
Bernier, Phosphoinositides regulate P2X4 ATP-gated channels through direct interactions. 2008, Pubmed , Xenbase
Bernier, Direct modulation of P2X1 receptor-channels by the lipid phosphatidylinositol 4,5-bisphosphate. 2008, Pubmed , Xenbase
Brake, New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. 1994, Pubmed , Xenbase
Burnstock, Do some nerve cells release more than one transmitter? 1976, Pubmed
Burnstock, P2X receptors in health and disease. 2011, Pubmed
Burnstock, The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression. 2018, Pubmed
Chataigneau, Exploring the ATP-binding site of P2X receptors. 2013, Pubmed
Cheewatrakoolpong, Identification and characterization of splice variants of the human P2X7 ATP channel. 2005, Pubmed
Chen, MolProbity: all-atom structure validation for macromolecular crystallography. 2010, Pubmed
Costa-Junior, C terminus of the P2X7 receptor: treasure hunting. 2011, Pubmed
DiMaio, Improved low-resolution crystallographic refinement with Phenix and Rosetta. 2013, Pubmed
Elliott, Membrane phosphatidylserine distribution as a non-apoptotic signalling mechanism in lymphocytes. 2005, Pubmed
el-Moatassim, A novel pathway for the activation of phospholipase D by P2z purinergic receptors in BAC1.2F5 macrophages. 1992, Pubmed
Emsley, Coot: model-building tools for molecular graphics. 2004, Pubmed
Fountain, An evolutionary history of P2X receptors. 2009, Pubmed
Franklin, The important role of the apoptotic effects of zinc in the development of cancers. 2009, Pubmed
Goehring, Screening and large-scale expression of membrane proteins in mammalian cells for structural studies. 2014, Pubmed
Gonnord, Palmitoylation of the P2X7 receptor, an ATP-gated channel, controls its expression and association with lipid rafts. 2009, Pubmed
Gubitosi-Klug, The human Kv1.1 channel is palmitoylated, modulating voltage sensing: Identification of a palmitoylation consensus sequence. 2005, Pubmed
Habermacher, Molecular structure and function of P2X receptors. 2016, Pubmed
Harkat, On the permeation of large organic cations through the pore of ATP-gated P2X receptors. 2017, Pubmed
Hattori, Molecular mechanism of ATP binding and ion channel activation in P2X receptors. 2012, Pubmed
Hausmann, A hydrophobic residue in position 15 of the rP2X3 receptor slows desensitization and reveals properties beneficial for pharmacological analysis and high-throughput screening. 2014, Pubmed
Holm, Using Dali for structural comparison of proteins. 2006, Pubmed
Humphreys, Induction of the P2z/P2X7 nucleotide receptor and associated phospholipase D activity by lipopolysaccharide and IFN-gamma in the human THP-1 monocytic cell line. 1996, Pubmed
Jarvis, ATP-gated P2X cation-channels. 2009, Pubmed
Karasawa, The P2X7 receptor forms a dye-permeable pore independent of its intracellular domain but dependent on membrane lipid composition. 2017, Pubmed
Karasawa, Structural basis for subtype-specific inhibition of the P2X7 receptor. 2016, Pubmed
Kasuya, Structural insights into the competitive inhibition of the ATP-gated P2X receptor channel. 2017, Pubmed
Kawate, Crystal structure of the ATP-gated P2X(4) ion channel in the closed state. 2009, Pubmed
Kawate, P2X Receptor Activation. 2017, Pubmed
Kochańczyk, Relationship between the architecture of zinc coordination and zinc binding affinity in proteins--insights into zinc regulation. 2015, Pubmed
Koshimizu, Identification of amino acid residues contributing to desensitization of the P2X2 receptor channel. 1998, Pubmed
Koshimizu, Contributions of the C-terminal domain to the control of P2X receptor desensitization. 1999, Pubmed
Li, Molecular mechanisms of human P2X3 receptor channel activation and modulation by divalent cation bound ATP. 2019, Pubmed
Li, Physical basis of apparent pore dilation of ATP-activated P2X receptor channels. 2015, Pubmed
Mackenzie, Pseudoapoptosis induced by brief activation of ATP-gated P2X7 receptors. 2005, Pubmed
Mansoor, X-ray structures define human P2X(3) receptor gating cycle and antagonist action. 2016, Pubmed
Mastronarde, Automated electron microscope tomography using robust prediction of specimen movements. 2005, Pubmed
Migita, Polar residues of the second transmembrane domain influence cation permeability of the ATP-gated P2X(2) receptor. 2001, Pubmed
Murrell-Lagnado, Regulation of P2X Purinergic Receptor Signaling by Cholesterol. 2017, Pubmed
Naumenko, Palmitoylation as a Functional Regulator of Neurotransmitter Receptors. 2018, Pubmed
North, P2X receptors as drug targets. 2013, Pubmed
North, Molecular physiology of P2X receptors. 2002, Pubmed
Pelegrin, Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor. 2006, Pubmed
Pettersen, UCSF Chimera--a visualization system for exploratory research and analysis. 2004, Pubmed
Peverini, New Insights Into Permeation of Large Cations Through ATP-Gated P2X Receptors. 2018, Pubmed
Pippel, Localization of the gate and selectivity filter of the full-length P2X7 receptor. 2017, Pubmed
Punjani, cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. 2017, Pubmed
Qin, Unique regulatory properties of the type 2a Ca2+ channel beta subunit caused by palmitoylation. 1998, Pubmed , Xenbase
Quick, Monitoring the function of membrane transport proteins in detergent-solubilized form. 2007, Pubmed
Reeves, Structure and function in rhodopsin: high-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line. 2002, Pubmed
Robinson, Plasma membrane cholesterol as a regulator of human and rodent P2X7 receptor activation and sensitization. 2014, Pubmed
Roger, C-terminal calmodulin-binding motif differentially controls human and rat P2X7 receptor current facilitation. 2010, Pubmed
Roger, Facilitation of P2X7 receptor currents and membrane blebbing via constitutive and dynamic calmodulin binding. 2008, Pubmed
Rokic, Two open states of P2X receptor channels. 2013, Pubmed
Rysavy, Beyond apoptosis: the mechanism and function of phosphatidylserine asymmetry in the membrane of activating mast cells. 2014, Pubmed
Scheres, RELION: implementation of a Bayesian approach to cryo-EM structure determination. 2012, Pubmed
Shipston, Ion channel regulation by protein palmitoylation. 2011, Pubmed
Shipston, Ion channel regulation by protein S-acylation. 2014, Pubmed
Smith, Identification of amino acids within the P2X2 receptor C-terminus that regulate desensitization. 1999, Pubmed , Xenbase
Stank, Protein Binding Pocket Dynamics. 2016, Pubmed
Stephens, The alpha1B Ca2+ channel amino terminus contributes determinants for beta subunit-mediated voltage-dependent inactivation properties. 2000, Pubmed
Surprenant, The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). 1996, Pubmed
Traut, Physiological concentrations of purines and pyrimidines. 1994, Pubmed
Ugur, A Mechanism-Based Approach to P2X7 Receptor Action. 2019, Pubmed
Valera, A new class of ligand-gated ion channel defined by P2x receptor for extracellular ATP. 1994, Pubmed , Xenbase
Virginio, Pore dilation of neuronal P2X receptor channels. 1999, Pubmed
Voss, DoG Picker and TiltPicker: software tools to facilitate particle selection in single particle electron microscopy. 2009, Pubmed
Webb, Cloning and functional expression of a brain G-protein-coupled ATP receptor. 1993, Pubmed , Xenbase
Werner, Domains of P2X receptors involved in desensitization. 1996, Pubmed , Xenbase
Wilson, Epithelial membrane proteins induce membrane blebbing and interact with the P2X7 receptor C terminus. 2002, Pubmed
Zhang, Gctf: Real-time CTF determination and correction. 2016, Pubmed
Zheng, MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. 2017, Pubmed